New weapon tested against superbug pneumonia
NCT ID NCT07492771
Summary
This is an early safety study testing a new drug called MP101 for adults with a specific, hard-to-treat bacterial pneumonia caused by Pseudomonas aeruginosa. The main goal is to see if MP101 is safe and how it behaves in the body when given alongside standard antibiotics. It's a small, first-in-human trial designed to gather initial data before larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA, BACTERIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Severance Hospital
Seoul, Seodaemun-gu, 03722, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.